Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsHerbal medicines for the treatment of inflammatory bowel diseaseHerbal and plant therapy in patients with inflammatory bowel diseaseBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewSystematic review: the efficacy of herbal therapy in inflammatory bowel diseaseUse of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologistsDistinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicineDoctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel diseaseBeliefs about asthma and complementary and alternative medicine in low-income inner-city African-American adults.Review article: complementary and alternative therapies for inflammatory bowel disease.Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.Complementary Therapies in Inflammatory Bowel Diseases.Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study.Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease
P2860
Q22242050-CE1C1D78-ACF2-4775-B249-4CD2995ACF5DQ24194984-3C4D702F-5DCA-48F8-971C-1F5AF568010CQ26823835-2DB8268E-0048-4C7B-91D3-8D226982EAD7Q26998841-367DA7C7-E71A-4EB3-A023-F7BF703C85FCQ27004516-0F28019B-3C0C-42DC-AD80-BE3A37B7382DQ33244259-A301B81B-A766-49C7-A084-69A175C7E9D1Q33810124-DE99E209-0981-4F7C-B0A3-F152B02CB083Q34075201-C80585E0-C504-48A1-A222-804E1212E253Q34152778-B3B162D7-3ACF-49C3-AC13-58D2C57857F3Q34191499-44F53166-028F-4A59-AC97-E29D7CB35728Q34410515-BD0B024B-174F-40A3-910F-BA833ADB8C26Q34454367-EB62EA1F-C6AC-482E-9767-17E123A552E6Q34629572-6337B372-C0AD-4817-B0CC-5D095B9D0C43Q35064501-737A184A-2E6B-4ECB-9FBB-C01384DD0154Q35221841-2644948A-E0B5-4E8A-8BC1-B0095F88E300Q35901646-340B3816-42A9-49DE-B32B-C4CC17D072A2Q36372525-49566C88-79CE-4410-9DEA-3BDB87964D80Q37312768-7CF0918D-4212-42EA-9F0C-9974D1F84C55Q37542865-F8AA338A-0981-4278-939F-A1B1BD81C79EQ37789695-27E06F98-CA98-4C8F-8159-08E55C871DE5Q37992245-101727A2-E0C9-4B2D-A9F1-F665807D666FQ38016381-0706D84A-D217-4760-8F1D-B1460EE7598FQ38083493-136CA8FE-AD3C-4CC9-B1EC-394D431EC984Q38982194-F968D932-39A1-4AFB-BF4B-B66822AFAA7EQ42788674-07887D79-F0EA-4D85-83FB-4F12E5E097ABQ48437869-D92B2DC7-87CD-4724-BB06-12C854D298CDQ51227314-06733554-8F65-424E-B306-211CB1FDE1A7Q53192227-34A61E26-1CB2-442C-848D-257284FD7F47Q56638525-4263ED27-EBE4-4B2D-ABFA-2B5CCBC90C3A
P2860
Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Amount of systemic steroid med ...... from a German national survey.
@en
type
label
Amount of systemic steroid med ...... from a German national survey.
@en
prefLabel
Amount of systemic steroid med ...... from a German national survey.
@en
P2093
P2860
P1476
Amount of systemic steroid med ...... from a German national survey.
@en
P2093
Andreas Michalsen
Guenther Spahn
Gustav J Dobos
Inga B Anthonisen
Jost Langhorst
Rainer Lüdtke
Ulf Steder-Neukamm
P2860
P304
P356
10.1097/01.MIB.0000160771.71328.6C
P577
2005-03-01T00:00:00Z